新型冠狀病毒肺炎對於愛滋病患者的相關影響

10.6666/ClinMed.202108_88(2).0080

巫炳峰

人類免疫不全病毒（human immunodeficiency virus, HIV） ； 2019新型冠狀肺炎（coronavirus disease 2019, COVID-19） ； 新型冠狀病毒（severe acute respiratory syndrome coronavirus 2, SARS-CoV-2） ； 抗反轉錄病毒藥物治療（antiretroviral therapy）

臨床醫學月刊

88卷2期（2021 / 08 / 27）

483 - 489

繁體中文

2019年新型冠狀病毒肺炎（COVID-19）於2019年12月首次在中國武漢被發現。2020年3月，世界衛生組織宣布COVID-19為全球大流行疾病。患有多重慢性疾病的人感染COVID-19的風險可能更大，並且可能會出現嚴重的併發症。COVID-19有可能以各種方式影響愛滋病患者，包括增加感染COVID-19的風險以及中斷HIV相關的就醫治療。本篇文章主要目的是評估COVID-19對於愛滋病患者的影響。內容分為4個主題，包括：（1）SARS-CoV-2和HIV感染者的病理生理學和宿主免疫反應；（2）SARS-CoV-2和HIV合併感染者的臨床表現和治療結果；（3）評估抗反轉錄病毒藥物對感染COVID-19的愛滋病患者之影響；（4）觀察COVID-19大流行對愛滋病患者就醫服務的影響。

1. Akalin, E,Azzi, Y,Bartash, R(2020).Covid-19 and Kidney Transplantation.N Engl J Med,382,2475-2477.
2. Bhaskaran, K,Rentsch, CT,MacKenna, B(2021).HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform.Lancet HIV,8,e24-e32.
3. Blanco, JL,Ambrosioni, J,Garcia, F(2020).COVID-19 in patients with HIV: clinical case series.Lancet HIV,7,e314-e316.
4. Cao, B,Wang, Y,Wen, D(2020).A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.N Engl J Med,382,1787-1799.
5. Chan, JF,Yao, Y,Yeung, ML(2015).Treatment With Lopinavir/Ritonavir or Interferon-beta1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset.J Infect Dis,212,1904-1913.
6. Childs, K,Post, FA,Norcross, C(2020).Hospitalized Patients With COVID-19 and Human Immunodeficiency Virus: A Case Series.Clin Infect Dis,71,2021-2022.
7. Choy, KT,Wong, AY,Kaewpreedee, P(2020).Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro.Antiviral Res,178,104786.
8. Consortium WHOST,Pan, H,Peto, R(2021).Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.N Engl J Med,384,497-511.
9. De Meyer, S,Bojkova, D,Cinatl, J(2020).Lack of antiviral activity of darunavir against SARS-CoV-2.Int J Infect Dis,97,7-10.
10. Du, F,Liu, B,Zhang, S(2021).COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness.J Thromb Thrombolysis,51,313-329.
11. Elfiky, AA(2020).Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase(RdRp): A molecular docking study.Life Sci,253,117592.
12. El-Sadr, WM,Justman, J(2020).Africa in the Path of Covid-19.N Engl J Med,383,e11.
13. Gervasoni, C,Meraviglia, P,Riva, A(2020).Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19.Clin Infect Dis,71,2276-2278.
14. Group RC(2020).Lopinavir-ritonavir in patients admitted to hospital with COVID-19(RECOVERY): a randomised, controlled, open-label, platform trial.Lancet
15. Gudipati, S,Brar, I,Murray, S(2020).Descriptive Analysis of Patients Living With HIV Affected by COVID-19.J Acquir Immune Defic Syndr,85,123-126.
16. Guo W, Ming F, Dong Y, et al. A survey for COVID19 among HIV/AIDS patients in two districts of Wuhan. SSRN: China 2020.
17. Guo, W,Weng, HL,Bai, H(2020).[Quick community survey on the impact of COVID-19 outbreak for the healthcare of people living with HIV].Zhonghua Liu Xing Bing Xue Za Zhi,41,662-666.
18. Hadi, YB,Naqvi, SFZ,Kupec, JT(2020).Characteristics and outcomes of COVID-19 in patients with HIV: a multicentre research network study.AIDS,34,F3-F8.
19. Ho, HE,Peluso, MJ,Margus, C(2021).Clinical Outcomes and Immunologic Characteristics of Coronavirus Disease 2019 in People With Human Immunodeficiency Virus.J Infect Dis,223,403-408.
20. Jewell, BL,Mudimu, E,Stover, J(2020).Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models.Lancet HIV,7,e629-e640.
21. Karmen-Tuohy, S,Carlucci, PM,Zervou, FN(2020).Outcomes Among HIV-Positive Patients Hospitalized With COVID-19.J Acquir Immune Defic Syndr,85,6-10.
22. Klok, FA,Kruip, M,van der Meer, NJM(2020).Incidence of thrombotic complications in critically ill ICU patients with COVID-19.Thromb Res,191,145-147.
23. Koehler, P,Cornely, OA,Bottiger, BW(2020).COVID-19 associated pulmonary aspergillosis.Mycoses,63,528-534.
24. Kowalska, JD,Skrzat-Klapaczynska, A,Bursa, D(2020).HIV care in times of the COVID-19 crisis - Where are we now in Central and Eastern Europe?.Int J Infect Dis,96,311-314.
25. Magro, C,Mulvey, JJ,Berlin, D(2020).Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.Transl Res,220,1-13.
26. Malek, J,Rogers, R,Kufera, J(2011).Venous thromboembolic disease in the HIV-infected patient.Am J Emerg Med,29,278-282.
27. Meyerowitz, EA,Kim, AY,Ard, KL(2020).Disproportionate burden of coronavirus disease 2019 among racial minorities and those in congregate settings among a large cohort of people with HIV.AIDS,34,1781-1787.
28. Richardson, S,Hirsch, JS,Narasimhan, M(2020).Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.JAMA,323,2052-2059.
29. Riva, A,Conti, F,Bernacchia, D(2020).Darunavir does not prevent SARS-CoV-2 infection in HIV patients.Pharmacol Res,157,104826.
30. Rockwell, KL,Gilroy, AS(2020).Incorporating telemedicine as part of COVID-19 outbreak response systems.Am J Manag Care,26,147-148.
31. Rutsaert, L,Steinfort, N,Van Hunsel, T(2020).COVID-19-associated invasive pulmonary aspergillosis.Ann Intensive Care,10,71.
32. Shalev, N,Scherer, M,LaSota, ED(2020).Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019.Clin Infect Dis,71,2294-2297.
33. Sigel, K,Swartz, T,Golden, E(2020).Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City.Clin Infect Dis,71,2933-2938.
34. Sun, S,Hou, J,Chen, Y(2020).Challenges to HIV Care and Psychological Health During the COVID-19 Pandemic Among People Living with HIV in China.AIDS Behav,24,2764-2765.
35. Vizcarra, P,Perez-Elias, MJ,Quereda, C(2020).Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort.Lancet HIV,7,e554-e564.
36. Wang, D,Hu, B,Hu, C(2020).Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.JAMA,323,1061-1069.
37. Zhu, F,Cao, Y,Xu, S(2020).Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China.J Med Virol,92,529-530.
38. Zou, X,Chen, K,Zou, J(2020).Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.Front Med,14,185-192.